Nuvation Bio Inc (NUVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -41,659 | N/A | N/A | N/A |
| Depreciation Amortization | 103 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 34 | N/A | N/A | N/A |
| Other Working Capital | 2,110 | N/A | N/A | N/A |
| Other Operating Activity | 2,883 | 0 | 0 | 0 |
| Operating Cash Flow | $-36,529 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| Change In Deposits | -72,683 | N/A | N/A | N/A |
| PPE Investments | -145 | N/A | N/A | N/A |
| Purchase Of Investment | 2,508 | N/A | N/A | N/A |
| Investing Cash Flow | $-70,320 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Other Financing Activity | 133,135 | 0 | 0 | 0 |
| Financing Cash Flow | $133,135 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 3,469 | N/A | N/A | N/A |
| End Cash Position | 29,755 | N/A | N/A | N/A |
| Net Cash Flow | $26,286 | $N/A | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -36,529 | N/A | N/A | N/A |
| Capital Expenditure | -145 | N/A | N/A | N/A |
| Free Cash Flow | -36,674 | 0 | 0 | 0 |